Meet JD, who was diagnosed with HLH, an immune deficiency disorder, at 2 weeks old. He came to Cincinnati Children’s, where he first met Dr. Kumar. JD is dressing up as @AshishKumar_md for Halloween because his family says he and the entire team have been “absolutely amazing”!
Attention @Reds fans - grab a piece of memorabilia from the 2021 NL Rookie of the Year.
Repost and comment for a chance to win this Jonathan India broken bat.
No purchase necessary. 18+. Ends 9:00pm ET on 8/28. Restrictions apply; see Official Rules: https://t.co/YjkYgQbtat
🔊 ALERT 🩺 TA-TMA WEBINAR Tomorrow! 📅 Wednesday, April 17th 12-1pm CST
📺 The Past, Present & Future of TA-TMA Targeted Therapies
Presented by Anthony Sabulski, MD and moderated by Steve Kleiboeker, PhD.
REGISTER NOW 👇
#bmtsm#ATC2024Philly#HSCT#MedTwitter
Bad news: Noelvi Marte tested positive for a banned substance. It’s dumb, inexcusable, and a let down for the entire organization.
Good news: The Reds have 18 other infielders.
#ATOBTTR
Graft rejection post transplant driven by interferon gamma with biomarkers LAG3 and CXCL11. Can we prevent graft rejection by blocking interferon gamma signaling in high risk patients? Nice work @TonySabulski@ASTCT#Tandem24
Excellent talk at the Best Abstract session of #Tandem24 by Dr. Tony Sabulski on the role of ferroptosis in graft rejection after #HCT@TonySabulski@ChildrensCBDI
Excellent talk by Nathan Leubbering on chemokine responses to BK infection post #HCT and the contribution of MAIT cells @ChildrensCBDI@BmtCincy#Tandem24
A first-in-human study at Cincinnati Children’s suggests that a novel cell therapy could correct telomere shortening in patients with telomere biology disorders (TBDs). @KMyersBMT is the principal investigator for the study. Learn more: https://t.co/i33Nk9Ypf5